In vivo experiments with nude mice showed that KCNQ1DN overexpression repressed both the growth of xenograft tumors and the expression of the oncogen c-Myc, thus representing a novel target for future therapeutic options in RCC [96]. The gene discussed is KCNQ1DN; the disease is renal cell carcinoma.